|
|
|
| Delve into the how of aseptic processing at the 2025 ISPE Aseptic Conference. Explore a wide range of topics including real-time environmental monitoring, transitioning from restricted access barrier systems to isolator operations, advanced filling technologies, sterility testing in cell and tissue therapies, and implementing Annex 1 across global manufacturing networks. Additionally, learn about ATMP resiliency, contamination prevention, and emerging technologies related to bio-decontamination. Visit ISPE.org/aseptic25. |
|
|
|
|
|
|
|
|
| Contamination Control Strategy With QRM Principles | Webinar | Koerber Pharma | Contamination Control Strategies (CCS) have long been a main concept, but advancing requirements and regulatory expectations create a challenge. Learn how to be effective and compliant with your CCS. |
|
|
| Vial Containment Systems Based On Elastomer 4031/45 Gray | Article | By T. Page McAndrew, Ph.D., and Victoria Morgan, West Pharmaceutical Services, Inc. | Examine the results of two, two-year studies that indicate good container closure integrity performance that can be achieved with stoppers of a given elastomer, independent of configuration. |
|
|
|
|
| Five Tests For Pharmaceutical Containment | Article | Flow Sciences Inc. | As APIs increase in potency and become more hazardous, delve into different containment methods and determine which would be most beneficial for your first (or next) containment device. |
|
|
|
|
|
|
By Ravali Patlolla, Freyr Solutions | The Generic Drug User Fee Amendments (GDUFA) program has been a cornerstone of the FDA's efforts. 2025 marks the midpoint of the current GDUFA III program, so it's a good time to refresh yourself with requirements and facility readiness. | |
|
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|